Group CBT for Depression and AOD Disorders
BRIGHT2
Group Cognitive Behavioral Therapy for Depression and Alcohol and Other Drug Disorders
1 other identifier
interventional
73
1 country
1
Brief Summary
The investigators will adapt and test an existing treatment (group CBT for depression) for use in outpatient substance use treatment settings as delivered by trained substance use counselors. The investigators expect that treatment will lead to improved depression and substance use outcomes.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for phase_1 depression
Started Sep 2006
Typical duration for phase_1 depression
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 1, 2006
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2009
CompletedStudy Completion
Last participant's last visit for all outcomes
September 1, 2009
CompletedFirst Submitted
Initial submission to the registry
June 29, 2010
CompletedFirst Posted
Study publicly available on registry
June 30, 2010
CompletedNovember 16, 2011
November 1, 2011
3 years
June 29, 2010
November 10, 2011
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Reductions in depressive symptoms as measured by the BDI II
Post treatment
Reductions in AOD use
Post treatment
Study Arms (2)
1
EXPERIMENTALClients are invited to attend 18 group CBT sessions
2
NO INTERVENTIONClients receive usual care
Interventions
Eligibility Criteria
You may qualify if:
- Enrolled in outpatient substance abuse program
- BDI II score \>13
- Probable alcohol or substance use problem
You may not qualify if:
- Cognitive impairment (Short Blessed \> 10)
- Probably bipolar or schizophrenic disorder
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- RANDlead
- Behavioral Health Services, Inc.collaborator
Study Sites (1)
Behavioral Health Services, Inc
Gardena, California, 90249, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Katherine E Watkins, MD, MSHS
RAND
Study Design
- Study Type
- interventional
- Phase
- phase 1
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 29, 2010
First Posted
June 30, 2010
Study Start
September 1, 2006
Primary Completion
September 1, 2009
Study Completion
September 1, 2009
Last Updated
November 16, 2011
Record last verified: 2011-11